A multiparametric MRI (mpMRI) of the prostate is an advanced, non‑invasive scan combining high‑resolution anatomical imaging (T2‑weighted) with functional sequences—diffusion‑weighted imaging and dynamic contrast‑enhanced imaging (and sometimes spectroscopy). It improves detection and localization of clinically significant prostate cancer, helps stage disease, guides targeted biopsy and active‑surveillance decisions, and is reported using standardized PI‑RADS scores to assess cancer likelihood.

Costs vary by country and facility. In the U.S. an outpatient prostate multiparametric MRI typically ranges from about $500–$3,000; in the U.K. private scans often cost £400–£1,000, while in India prices commonly range ₹5,000–₹20,000. Public health systems may provide it free or at low cost if clinically indicated; insurance often covers it when recommended. Additional fees may apply for contrast or radiologist report.

Multiparametric MRI (mpMRI) of the prostate is the preferred scan — combining high-resolution T2-weighted imaging, diffusion-weighted imaging (DWI/ADC), and dynamic contrast-enhanced (DCE) sequences. A 3 Tesla (3T) scanner offers superior spatial resolution; if 3T is unavailable, 1.5T with an endorectal coil can improve quality. mpMRI with PI‑RADS reporting is standard for detection, targeted biopsy planning, and staging.

After a prostate mpMRI, a radiologist reviews images and assigns a PI‑RADS score indicating likelihood of clinically significant cancer. The report is sent to your referring clinician, who discusses results and next steps. PI‑RADS 1–2 usually means monitoring; 3 is indeterminate; 4–5 often leads to targeted biopsy and urology referral. Results typically arrive within days to a couple of weeks and guide further testing or treatment.

mpMRI improves detection of clinically significant prostate cancer and can reduce unnecessary biopsies by guiding targeted sampling. However, biopsy remains the diagnostic gold standard because tissue is required for definitive diagnosis, grading, and molecular testing. A negative mpMRI does not fully exclude cancer when clinical suspicion is high, so biopsy may still be recommended in those cases.

A prostate multiparametric MRI scan typically takes about 30–45 minutes of imaging time. Including check‑in, positioning, and any contrast injection, expect a total appointment of roughly 45–60 minutes. Times vary by centre, whether an endorectal coil is used, and specific sequences ordered; occasionally scans run shorter (20–30 minutes) or longer (up to 75 minutes) for complex cases.